Early Life Intervention in Pediatrics Supported by E-health
Recruiting · NCT06208345 · Interventional (participants receive a specific treatment)
View the official record on ClinicalTrials.gov →Interventions studied
Life-Style app
What this trial is about
Childhood obesity in early life contributes to the development of specific NCDs, i.e. adult obesity. Unhealthy diet and low level of physical activity are lifestyle risk behaviors associated with chronic, systemic inflammation, which promotes the pathogenesis of NCDs. Early preventive measures to improve lifestyle behavior are of utmost importance. The aim of ELIPSE-I is to assess whether an eHealth application intervention for parents is feasible and efficacious in lowering total energy intake/total energy expenditure (TEI/TEE) ratio in their children with BMI \>97 centile (ELIPSE-I).
Who can take part
Age range
6 Years to 12 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- German speaking parents
- Any ethnic background/race
- Children should live/grow-up in the same household as the parental participant
- Children with an age- and sex-matched BMI \>97 centile according to Swiss national growth charts
- Children who attend the outpatient weight management clinic at the Division of Pediatric Endocrinology at the University Children's Hospital Bern
- Signed informed consent form from parent(s)
Exclusion criteria
- Syndromic obesity
- Known congenital disease affecting musculo-skeletal, cardiac or pulmonary function
- Participation in another clinical trial targeting similar objectives
Where it is running
1 location listed.
- Department of Paediatrics, Inselspital, Bern University Hospital - Bern, Switzerland